Comprehensive Clinical Development, Inc.
KCO was retained as Financial Advisors to the Unsecured Creditors Committee. The Debtors operated as clinical research companies that provide contract services of over 200 clinical trials per year focusing on clinical pharmacology, central nervous system and oncology. Our role was to provide an objective assessment of the business plans and budgets.
